Exploring Sirtuins: New Frontiers in Managing Heart Failure with Preserved Ejection Fraction

被引：1
|
作者：
Lu, Ying [1 ]
Li, Yongnan [2 ]
Xie, Yixin [1 ]
Bu, Jiale [1 ]
Yuan, Ruowen [1 ]
Zhang, Xiaowei [1 ]
机构：
[1] Lanzhou Univ, Hosp 2, Dept Cardiol, Lanzhou 730031, Peoples R China
[2] Lanzhou Univ, Hosp 2, Dept Cardiac Surg, Lanzhou 730031, Peoples R China
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2024年 / 25卷 / 14期
基金：
中国国家自然科学基金;
关键词：
SIRTs; heart failure; heart failure with preserved ejection fraction; left ventricular diastolic dysfunction; development; treatment; DIASTOLIC FUNCTION; CARDIAC FIBROSIS; SIRT1; ACTIVATOR; SEX-DIFFERENCES; MOUSE MODEL; GENDER; PROTECTS; SRT2104; HYPERTROPHY; RESISTANCE;
D O I：
10.3390/ijms25147740
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
With increasing research, the sirtuin (SIRT) protein family has become increasingly understood. Studies have demonstrated that SIRTs can aid in metabolism and affect various physiological processes, such as atherosclerosis, heart failure (HF), hypertension, type 2 diabetes, and other related disorders. Although the pathogenesis of HF with preserved ejection fraction (HFpEF) has not yet been clarified, SIRTs have a role in its development. Therefore, SIRTs may offer a fresh approach to the diagnosis, treatment, and prevention of HFpEF as a novel therapeutic intervention target.
引用
收藏
页数：22
相关论文
共 50 条
  • [1] Managing heart failure with preserved ejection fraction
    Davidson, Alexander
    Raviendran, Nivashinie
    Murali, Charisma Nair
    Myint, Phyo Kyaw
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [2] Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction
    Butler, Javed
    Hamo, Carine E.
    Udelson, James E.
    Pitt, Bertram
    Yancy, Clyde
    Shah, Sanjiv J.
    Desvigne-Nickens, Patrice
    Bernstein, Harold S.
    Clark, Richard L.
    Depre, Christophe
    Dinh, Wilfried
    Hamer, Andrew
    Kay-Mugford, Patricia
    Kramer, Frank
    Lefkowitz, Martin
    Lewis, Kelly
    Maya, Juan
    Maybaum, Simon
    Patel, Mahesh J.
    Pollack, Pia S.
    Roessig, Lothar
    Rotman, Sarit
    Salsali, Afshin
    Sims, J. Jason
    Senni, Michele
    Rosano, Giuseppe
    Dunnmon, Preston
    Stockbridge, Norman
    Anker, Stefan D.
    Zile, Michael R.
    Gheorghiade, Mihai
    CIRCULATION-HEART FAILURE, 2016, 9 (11)
  • [3] EXPLORING NEW TREATMENT OPTIONS FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Shah, Shailee Y.
    Litwin, Sheldon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 2324 - 2324
  • [4] Metabolic therapy for managing heart failure with preserved ejection fraction
    Sedej, Simon
    Abdellatif, Mahmoud
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 168 : 68 - 69
  • [5] Nonpharmacological Approaches to Managing Heart Failure With Preserved Ejection Fraction
    Tang, Feiyang
    Han, Haofu
    Fu, Sheng
    Liu, Qiming
    Zhou, Shenghua
    Huang, Jiapeng
    Xiao, Yichao
    CIRCULATION-HEART FAILURE, 2024, 17 (08)
  • [6] Heart failure with preserved ejection fraction
    Kessler, Kenneth M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17): : 1829 - 1829
  • [7] Heart Failure with Preserved Ejection Fraction
    Meyer, Adam
    Kerrigan, Martin
    HOSPITAL MEDICINE CLINICS, 2015, 4 (03) : 283 - 296
  • [8] Heart Failure with Preserved Ejection Fraction
    Gladden, James D.
    Chaanine, Antoine H.
    Redfield, Margaret M.
    ANNUAL REVIEW OF MEDICINE, VOL 69, 2018, 69 : 65 - 79
  • [9] Heart failure with preserved ejection fraction
    Marzia Rigolli
    Gillian A Whalley
    Journal of Geriatric Cardiology, 2013, 10 (04) : 369 - 376
  • [10] Heart Failure with Preserved Ejection Fraction
    Franssen, C.
    Paulus, W. J.
    NETHERLANDS JOURNAL OF CRITICAL CARE, 2012, 16 (04): : 125 - 132
12345